FNY Investment Advisers’s Surgery Partners SGRY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$208K Buy
15,034
+8,534
+131% +$128K 0.05% 214
2026
Q2
$109K Hold
6,500
– – 0.04% 316
2026
Q1
$77K Hold
6,500
– – 0.03% 315
2025
Q4
$100K Sell
6,500
-3,729
-36% -$68.5K 0.03% 343
2025
Q3
$221K Buy
10,229
+5,036
+97% +$112K 0.07% 259
2025
Q2
$115K Buy
+5,193
New +$115K 0.05% 286
2024
Q4
– Sell
-15,750
Closed -$507K – 900
2024
Q3
$507K Buy
+15,750
New +$465K 0.24% 98

Other funds holding SGRY

FNY Investment Advisers's SGRY Position: Q3 2026 in Review

FNY Investment Advisers increased its Surgery Partners (SGRY) stake by 131% in Q3 2026, buying an estimated $128K and bringing the position to 15,034 shares worth $208K. The position accounts for 0.05% of the portfolio, ranked #214.

FNY Investment Advisers first reported a position in SGRY in Q3 2024 and has held it in 7 quarters since. The position peaked at $507K in Q3 2024. 11 funds tracked by Wall St. Rank hold SGRY as of Q3 2026.

  • FNY Investment Advisers held 15,034 shares of Surgery Partners worth $208K as of Q3 2026.
  • FNY Investment Advisers bought 8,534 Surgery Partners shares in Q3 2026, an estimated $128K.
  • Surgery Partners made up 0.05% of FNY Investment Advisers's portfolio in Q3 2026, its #214 holding.
  • FNY Investment Advisers first reported a position in Surgery Partners in Q3 2024 and has held it in 7 quarters since.
  • FNY Investment Advisers's Surgery Partners position peaked at $507K in Q3 2024.
  • 11 funds tracked by Wall St. Rank held Surgery Partners as of Q3 2026.

Based on FNY Investment Advisers's 13F filing for Q3 2026, filed 16 Oct 2026.